Key Highlights
- Net loss per share was USD 1.49 against estimated Earnings of USD 0.15.
- Total revenues were negative USD 25.29 million, compared with negative USD 2.76 million.
- Net loss was USD 39.37 million, compared with USD 17.91 million.
- Cash was USD 7.48 million at September 30, 2026.
Beneficient (NASDAQ:BENF) reported total revenues of negative USD 25.29 million for the second quarter of fiscal 2027, the quarter ended September 30, 2026, compared with negative USD 2.76 million in the prior-year quarter. Net loss per Class A and Class B common share was USD 1.49, compared with USD 3.00, against an estimate of USD 0.15 in earnings per share.
The net loss was USD 39.37 million, compared with USD 17.91 million. The net loss attributable to Beneficient common shareholders was USD 22.06 million, compared with USD 3.63 million.
Fiscal Second Quarter Results
Investment loss, net, was USD 13.83 million, compared with USD 3.16 million, and the loss on financial instruments, net, was USD 11.55 million, compared with a gain of USD 211 thousand. Interest and Dividend income was USD 10 thousand, and trust services and administration revenues were USD 85 thousand, compared with USD 178 thousand.
Employee compensation and benefits expense was USD 2.79 million, compared with USD 2.43 million, and interest expense was USD 4.71 million, compared with USD 4.90 million. Professional services expense, net, was USD 3.49 million, compared with USD 5.33 million, the loss on Impairment of Goodwill was USD 1.48 million, and other expenses were USD 1.59 million, compared with USD 2.44 million.
Total operating expenses were USD 14.06 million, compared with USD 15.10 million. The loss before income taxes was USD 39.35 million, compared with USD 17.86 million, and income tax expense was USD 22 thousand, compared with USD 43 thousand. Per-share data reflect the 1-for-8 Reverse Stock Split effected on December 15, 2025.
Six-Month Results
For the six months ended September 30, 2026, total revenues were negative USD 13.12 million, compared with negative USD 15.39 million. Total operating expenses were USD 26.60 million, compared with USD 95.13 million, which included an accrual of a loss contingency related to an arbitration award of USD 62.83 million in the prior-year period.
The net loss was USD 39.75 million, compared with USD 110.56 million, and the net loss attributable to Beneficient common shareholders was USD 28.84 million, compared with USD 68.71 million. Net loss per common share was USD 1.97, compared with USD 58.68. Net cash used in Operating Activities was USD 14.16 million, compared with USD 25.36 million.
Balance Sheet and Going Concern Disclosure
Cash and cash equivalents were USD 7.48 million at September 30, 2026, compared with USD 2.54 million at March 31, 2026. Total Assets were USD 227.28 million, compared with USD 238.77 million, and total liabilities were USD 353.81 million, compared with USD 337.53 million.
The filing discloses substantial doubt about the company's ability to continue as a going concern. It cites the current inability to raise sufficient capital, recurring losses from operations, negative cash flows from operations, existing events of default on related party debts, delays in executing business plans and the confirmation by the Texas Court of Appeals of a previous Equity arbitration award.
Beneficient Fiscal Q2 2027 Earnings: Key Takeaways
Beneficient reported fiscal second quarter 2027 total revenues of negative USD 25.29 million and a net loss of USD 39.37 million. Cash was USD 7.48 million at September 30, 2026.






Please wait processing your request...